Compositions and methods for inhibiting expression of a gene from the Ebola

Details for Australian Patent Application No. 2008232891 (hide)

Owner Government of the United States as represented by The Secretary of the Army Alnylam Pharmaceuticals, Inc.

Inventors Borodovsky, Anna; Novobrantseva, Tatiana; Tan, Pamela; De Fougerolles, Antonin; Warfield, Kelly Lyn; Bavari, Sina

Agent FB Rice

Pub. Number AU-B-2008232891

PCT Pub. Number WO2008/121604

Priority 60/908,793 29.03.07 US

Filing date 25 March 2008

Wipo publication date 9 October 2008

Acceptance publication date 12 January 2012

International Classifications

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

15 October 2009 PCT application entered the National Phase

  PCT publication WO2008/121604 Priority application(s): WO2008/121604

12 January 2012 Application Accepted

  Published as AU-B-2008232891

10 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008232895-Apparatuses and methods for bone screw augmentation

2008232842-Insertion system for corneal implants